查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1140112

压疮市场：按类型、治疗类型和最终用户：2021-2031 年全球机会分析和行业预测

Pressure Ulcers Market By Type, By Treatment Type, By End user : Global Opportunity Analysis and Industry Forecast, 2021-2031
出版日期: | 出版商: Allied Market Research | 英文 321 Pages | 商品交期: 2-3个工作天内

价格

全球压疮市场预计将在 2021 年达到 37.208 亿美元，在 2031 年达到 56.122 亿美元，从 2022 年到 2031 年的复合年增长率为 4.2%。

压疮，也称为褥疮、褥疮或压疮，是皮肤和组织因长时间受压或摩擦而引起的损伤。压力性溃疡最常发生在□骨、足跟、下背部和尾骨的皮肤上。其他部位包括膝盖、肘部、脚踝和颅骨后部。据说压疮更容易发生在久坐不动的人、使用轮椅的人以及由于慢性病而无法移动的人身上。早期诊断能够进行治疗并减少与压疮相关的并发症的发生率，例如蜂窝织炎、败血症以及骨和关节感染。

压疮市场受到压疮患病率增加、老年人口增加、对压疮治疗效果的认识提高以及对伤口护理敷料产品需求增加的推动。例如，根据美国卫生与公众服务部伤口护理敷料的数据，到 2020 年，受压疮影响的美国人口将约为 250 万。根据伤口管理和预防，大约 71% 的压疮发生在 70 岁以上的人群中。

但是，高昂的治疗成本以及与药物相关的副作用（如胃部不适、噁心和血压升高）阻碍了市场增长。

内容

第一章介绍

第 2 章执行摘要

第 3 章市场概览

  • 市场定义和范围
  • 主要发现
    • 主要投资领域
  • 波特五力分析
  • 主要公司的定位
  • 市场动态
    • 驱动程序
    • 约束因素
    • 机会
  • COVID-19 影响分析

第 4 章压疮市场：按类型分类

  • 概览
    • 市场规模和预测
  • 第一阶段
    • 主要市场趋势、增长因素和机遇
    • 市场规模和预测：按地区
    • 市场分析：按国家/地区分类
  • 第 2 阶段
    • 主要市场趋势、增长动力和机遇
    • 市场规模和预测：按地区
    • 市场分析：按国家/地区分类
  • 第 3 阶段
    • 主要市场趋势、增长动力和机遇
    • 市场规模和预测：按地区
    • 市场分析：按国家/地区分类
  • 第 4 阶段
    • 主要市场趋势、增长因素和机遇
    • 市场规模和预测：按地区
    • 市场分析：按国家/地区分类
  • 深部组织损伤
    • 主要市场趋势、增长因素和机遇
    • 市场规模和预测：按地区
    • 市场分析：按国家/地区分类

第 5 章压疮市场：按治疗类型分类

  • 概览
    • 市场规模和预测
  • 伤口护理敷料
    • 主要市场趋势、增长因素和机遇
    • 市场规模和预测：按地区
    • 市场分析：按国家/地区分类
    • 伤口护理敷料压疮市场：按类型分类
      • 泡沫敷料市场规模和预测：按地区划分
      • 按地区划分的水胶体敷料市场规模和预测
      • 按地区划分的藻酸盐敷料市场规模和预测
      • 其他敷料的市场规模和预测：按地区划分
  • 伤口护理装置
    • 主要市场趋势、增长因素和机遇
    • 市场规模和预测：按地区
    • 市场分析：按国家/地区分类
    • 伤口护理设备压疮市场：按类型
      • 治疗设备市场规模和预测：按地区
      • 其他市场规模和预测：按地区
  • 其他
    • 主要市场趋势、增长因素和机遇
    • 市场规模和预测：按地区
    • 市场分析：按国家/地区分类

第 6 章压疮市场：按最终用户分类

  • 概览
    • 市场规模和预测
  • 医院
    • 主要市场趋势、增长动力和机遇
    • 市场规模和预测：按地区
    • 市场分析：按国家/地区分类
  • 居家护理
    • 主要市场趋势、增长因素和机遇
    • 市场规模和预测：按地区
    • 市场分析：按国家/地区分类
  • 其他
    • 主要市场趋势、增长因素和机遇
    • 市场规模和预测：按地区
    • 市场分析：按国家/地区分类

第 7 章压疮市场：按地区划分

  • 概览
    • 市场规模和预测
  • 北美
    • 主要趋势和机遇
    • 北美市场规模和预测：按类型
    • 北美市场规模和预测：按治疗类型
      • 北美伤口护理敷料压疮市场：按类型分类
      • 北美伤口治疗设备压疮市场：按类型
    • 北美市场规模和预测：按最终用户分类
    • 北美市场规模和预测：按国家/地区分类
      • 美国
      • 加拿大
      • 墨西哥
  • 欧洲
    • 主要趋势和机遇
    • 欧洲市场规模和预测：按类型
    • 欧洲市场规模和预测：按治疗类型
      • 欧洲伤口护理敷料压疮市场：按类型分类
      • 欧洲伤口护理设备压疮市场：按类型
    • 欧洲市场规模和预测：按最终用户分类
    • 欧洲市场规模和预测：按国家/地区分类
      • 德国
      • 法国
      • 英国
      • 意大利
      • 西班牙
      • 其他地区
  • 亚太地区
    • 主要趋势和机遇
    • 亚太市场规模和预测：按类型
    • 按治疗类型划分的亚太地区市场规模和预测
      • 亚太地区伤口护理敷料压疮市场，按类型
      • 亚太地区伤口护理设备压疮市场：按类型分类
    • 亚太市场规模和预测：按最终用户分类
    • 亚太地区的市场规模和预测：按国家/地区分类
      • 日本
      • 中国
      • 澳大利亚
      • 印度
      • 韩国
      • 其他亚太地区
  • LAMEA
    • 主要趋势和机遇
    • LAMEA 市场规模和预测：按类型
    • LAMEA 市场规模和预测：按治疗类型
      • LAMEA 伤口护理敷料压疮市场：按类型分类
      • LAMEA 伤口护理设备压疮市场：按类型
    • LAMEA 市场规模和预测：按最终用户分类
    • LAMEA 市场规模和预测：按国家/地区分类
      • 巴西
      • 沙特阿拉伯
      • 南非
      • LAMEA 的其余部分

第八章企业情况

  • 简介
  • 关键成功策略
  • 10 家主要公司的产品映射
  • 竞赛仪表板
  • 比赛热图
  • 主要发展

第 9 章公司简介

  • 3M Company
  • Abercrombie & Fitch Co（Hollister）
  • Anhui Jinye Industrial Co., Ltd
  • B. Braun Melungeon AG
  • Baxter International（Hill-Rom Holdings, Inc）
  • Cardinal Health Inc.
  • Coloplast Group
  • ConvaTec Group Plc
  • Essity（BSN medical）
  • Integra LifeSciences（Derma Sciences Inc）
  • Johnson and Johnson
  • Smith & Nephew plc
  • Stryker Corp
  • Tissue Regenix
  • Investor AB（Molnlycke Healthcare AB）
  • Wego Group（Foosin Medical Supplies Inc., Ltd.）
  • Shandong Chuangkang Biotechnology Co., Ltd.
Product Code: A11263

The global pressure ulcers market was valued at $3,720.8 million in 2021, and is projected to reach $5,612.2 million by 2031, registering a CAGR of 4.2% from 2022 to 2031. Pressure ulcers are also called as bed sores, pressure sores or decubitus ulcer are injuries to the skin and tissue due to prolonged pressure or pressure with friction on the skin. Pressure ulcers occurs most commonly on the skin present over sacrum, heels, hips and coccyx. The other affected sites are knees, elbows, ankles and back of cranium. Pressure ulcers develop in individuals who have sedentary lifestyle, continuously use wheelchair and those who are immobilized due to chronic diseases. Early-stage diagnosis enables treatments and reduce complications associated with pressure ulcers such as cellulitis, sepsis, bone and joint infections.

The pressure ulcers market driven by increasing prevalence of pressure ulcer, rise in geriatric population as they are more susceptible to develop pressure ulcers, rise in awareness about availability of treatments for pressure ulcers, and increasing demand for wound care dressings product boosts growth of the market. For instance, according to U.S Department of Health and Human Wound Care Dressings, around 2.5 million population of U.S affected by pressure ulcers in 2020. Moreover, according to Wound Management and Prevention, about 71% pressure ulcers develop in patients older than 70 years.

However, high cost of treatments, side effects associated with the drug treatments such as upset stomach, nausea and blood pressure hinder the growth of the market.

The global pressure ulcers market is segmented into type, treatment type, end user and region. By type the market is categorized into stage 1, stage 2, stage 3, stage 4 and deep tissue injuries. Depending on treatment type, it is fragmented into wound care dressing, wound care devices and others. On the basis of end user, it is divided into hospitals, homecare and others. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Major key players that operate in the global pressure ulcers market are 3M, Abercrombie & Fitch Co (Hollister), Anhui Jinye Industrial Co., Ltd., B. Braun Melungeon AG, Baxter International (Hill-Rom Holdings, Inc), Cardinal Health, Coloplast Group, ConvaTec Group Plc, Essity (BSN medical), Integra LifeSciences (Derma Sciences Inc), Investor AB (Molnlycke Healthcare AB), Johnson and Johnson, Shandong Chuangkang Biotechnology Co., Ltd., Smith & Nephew plc, Stryker, Tissue Regenix and Wego Group (Foosin Medical Supplies Inc., Ltd.)

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the pressure ulcers market analysis from 2021 to 2031 to identify the prevailing pressure ulcers market opportunities.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the pressure ulcers market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global pressure ulcers market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

By Type

  • Stage 1
  • Stage 2
  • Stage 3
  • Stage 4
  • Deep tissue injury

By Treatment Type

  • Wound Care Dressing
    • type
    • Foam Dressings
    • Hydrocolloid Dressings
    • Alginate Dressings
    • Other Dressings
  • Wound Care Devices
    • type
    • Therapy Devices
    • Others
  • Others

By End user

  • Hospitals
  • Homecare
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of LAMEA
  • Asia-Pacific
    • Japan
    • China
    • Australia
    • India
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA
  • Key Market Players
    • 3M Company
    • Abercrombie & Fitch Co (Hollister)
    • Anhui Jinye Industrial Co., Ltd
    • B. Braun Melungeon AG
    • Baxter International (Hill-Rom Holdings, Inc)
    • Cardinal Health Inc.
    • Coloplast Group
    • ConvaTec Group Plc
    • Essity (BSN medical)
    • Integra LifeSciences (Derma Sciences Inc)
    • Johnson and Johnson
    • Smith & Nephew plc
    • Stryker Corp
    • Tissue Regenix
    • Investor AB (Molnlycke Healthcare AB)
    • Wego Group (Foosin Medical Supplies Inc., Ltd.)
    • Shandong Chuangkang Biotechnology Co., Ltd.

TABLE OF CONTENTS

CHAPTER 1:INTRODUCTION

  • 1.1.Report description
  • 1.2.Key market segments
  • 1.3.Key benefits to the stakeholders
  • 1.4.Research Methodology
    • 1.4.1.Secondary research
    • 1.4.2.Primary research
    • 1.4.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

  • 2.1.Key findings of the study
  • 2.2.CXO Perspective

CHAPTER 3:MARKET OVERVIEW

  • 3.1.Market definition and scope
  • 3.2.Key findings
    • 3.2.1.Top investment pockets
  • 3.3.Porter's five forces analysis
  • 3.4.Top player positioning
  • 3.5.Market dynamics
    • 3.5.1.Drivers
    • 3.5.2.Restraints
    • 3.5.3.Opportunities
  • 3.6.COVID-19 Impact Analysis on the market

CHAPTER 4: PRESSURE ULCERS MARKET, BY TYPE

  • 4.1 Overview
    • 4.1.1 Market size and forecast
  • 4.2 Stage 1
    • 4.2.1 Key market trends, growth factors and opportunities
    • 4.2.2 Market size and forecast, by region
    • 4.2.3 Market analysis by country
  • 4.3 Stage 2
    • 4.3.1 Key market trends, growth factors and opportunities
    • 4.3.2 Market size and forecast, by region
    • 4.3.3 Market analysis by country
  • 4.4 Stage 3
    • 4.4.1 Key market trends, growth factors and opportunities
    • 4.4.2 Market size and forecast, by region
    • 4.4.3 Market analysis by country
  • 4.5 Stage 4
    • 4.5.1 Key market trends, growth factors and opportunities
    • 4.5.2 Market size and forecast, by region
    • 4.5.3 Market analysis by country
  • 4.6 Deep tissue injury
    • 4.6.1 Key market trends, growth factors and opportunities
    • 4.6.2 Market size and forecast, by region
    • 4.6.3 Market analysis by country

CHAPTER 5: PRESSURE ULCERS MARKET, BY TREATMENT TYPE

  • 5.1 Overview
    • 5.1.1 Market size and forecast
  • 5.2 Wound Care Dressing
    • 5.2.1 Key market trends, growth factors and opportunities
    • 5.2.2 Market size and forecast, by region
    • 5.2.3 Market analysis by country
    • 5.2.4 Wound Care Dressing Pressure Ulcers Market by type
      • 5.2.4.1 Foam Dressings Market size and forecast, by region
      • 5.2.4.2 Hydrocolloid Dressings Market size and forecast, by region
      • 5.2.4.3 Alginate Dressings Market size and forecast, by region
      • 5.2.4.4 Other Dressings Market size and forecast, by region
  • 5.3 Wound Care Devices
    • 5.3.1 Key market trends, growth factors and opportunities
    • 5.3.2 Market size and forecast, by region
    • 5.3.3 Market analysis by country
    • 5.3.4 Wound Care Devices Pressure Ulcers Market by type
      • 5.3.4.1 Therapy Devices Market size and forecast, by region
      • 5.3.4.2 Others Market size and forecast, by region
  • 5.4 Others
    • 5.4.1 Key market trends, growth factors and opportunities
    • 5.4.2 Market size and forecast, by region
    • 5.4.3 Market analysis by country

CHAPTER 6: PRESSURE ULCERS MARKET, BY END USER

  • 6.1 Overview
    • 6.1.1 Market size and forecast
  • 6.2 Hospitals
    • 6.2.1 Key market trends, growth factors and opportunities
    • 6.2.2 Market size and forecast, by region
    • 6.2.3 Market analysis by country
  • 6.3 Homecare
    • 6.3.1 Key market trends, growth factors and opportunities
    • 6.3.2 Market size and forecast, by region
    • 6.3.3 Market analysis by country
  • 6.4 Others
    • 6.4.1 Key market trends, growth factors and opportunities
    • 6.4.2 Market size and forecast, by region
    • 6.4.3 Market analysis by country

CHAPTER 7: PRESSURE ULCERS MARKET, BY REGION

  • 7.1 Overview
    • 7.1.1 Market size and forecast
  • 7.2 North America
    • 7.2.1 Key trends and opportunities
    • 7.2.2 North America Market size and forecast, by Type
    • 7.2.3 North America Market size and forecast, by Treatment Type
      • 7.2.3.1 North America Wound Care Dressing Pressure Ulcers Market by type
      • 7.2.3.2 North America Wound Care Devices Pressure Ulcers Market by type
    • 7.2.4 North America Market size and forecast, by End user
    • 7.2.5 North America Market size and forecast, by country
      • 7.2.5.1 U.S.
      • 7.2.5.1.1 Market size and forecast, by Type
      • 7.2.5.1.2 Market size and forecast, by Treatment Type
      • 7.2.5.1.3 Market size and forecast, by End user
      • 7.2.5.2 Canada
      • 7.2.5.2.1 Market size and forecast, by Type
      • 7.2.5.2.2 Market size and forecast, by Treatment Type
      • 7.2.5.2.3 Market size and forecast, by End user
      • 7.2.5.3 Mexico
      • 7.2.5.3.1 Market size and forecast, by Type
      • 7.2.5.3.2 Market size and forecast, by Treatment Type
      • 7.2.5.3.3 Market size and forecast, by End user
  • 7.3 Europe
    • 7.3.1 Key trends and opportunities
    • 7.3.2 Europe Market size and forecast, by Type
    • 7.3.3 Europe Market size and forecast, by Treatment Type
      • 7.3.3.1 Europe Wound Care Dressing Pressure Ulcers Market by type
      • 7.3.3.2 Europe Wound Care Devices Pressure Ulcers Market by type
    • 7.3.4 Europe Market size and forecast, by End user
    • 7.3.5 Europe Market size and forecast, by country
      • 7.3.5.1 Germany
      • 7.3.5.1.1 Market size and forecast, by Type
      • 7.3.5.1.2 Market size and forecast, by Treatment Type
      • 7.3.5.1.3 Market size and forecast, by End user
      • 7.3.5.2 France
      • 7.3.5.2.1 Market size and forecast, by Type
      • 7.3.5.2.2 Market size and forecast, by Treatment Type
      • 7.3.5.2.3 Market size and forecast, by End user
      • 7.3.5.3 UK
      • 7.3.5.3.1 Market size and forecast, by Type
      • 7.3.5.3.2 Market size and forecast, by Treatment Type
      • 7.3.5.3.3 Market size and forecast, by End user
      • 7.3.5.4 Italy
      • 7.3.5.4.1 Market size and forecast, by Type
      • 7.3.5.4.2 Market size and forecast, by Treatment Type
      • 7.3.5.4.3 Market size and forecast, by End user
      • 7.3.5.5 Spain
      • 7.3.5.5.1 Market size and forecast, by Type
      • 7.3.5.5.2 Market size and forecast, by Treatment Type
      • 7.3.5.5.3 Market size and forecast, by End user
      • 7.3.5.6 Rest of LAMEA
      • 7.3.5.6.1 Market size and forecast, by Type
      • 7.3.5.6.2 Market size and forecast, by Treatment Type
      • 7.3.5.6.3 Market size and forecast, by End user
  • 7.4 Asia-Pacific
    • 7.4.1 Key trends and opportunities
    • 7.4.2 Asia-Pacific Market size and forecast, by Type
    • 7.4.3 Asia-Pacific Market size and forecast, by Treatment Type
      • 7.4.3.1 Asia-Pacific Wound Care Dressing Pressure Ulcers Market by type
      • 7.4.3.2 Asia-Pacific Wound Care Devices Pressure Ulcers Market by type
    • 7.4.4 Asia-Pacific Market size and forecast, by End user
    • 7.4.5 Asia-Pacific Market size and forecast, by country
      • 7.4.5.1 Japan
      • 7.4.5.1.1 Market size and forecast, by Type
      • 7.4.5.1.2 Market size and forecast, by Treatment Type
      • 7.4.5.1.3 Market size and forecast, by End user
      • 7.4.5.2 China
      • 7.4.5.2.1 Market size and forecast, by Type
      • 7.4.5.2.2 Market size and forecast, by Treatment Type
      • 7.4.5.2.3 Market size and forecast, by End user
      • 7.4.5.3 Australia
      • 7.4.5.3.1 Market size and forecast, by Type
      • 7.4.5.3.2 Market size and forecast, by Treatment Type
      • 7.4.5.3.3 Market size and forecast, by End user
      • 7.4.5.4 India
      • 7.4.5.4.1 Market size and forecast, by Type
      • 7.4.5.4.2 Market size and forecast, by Treatment Type
      • 7.4.5.4.3 Market size and forecast, by End user
      • 7.4.5.5 South Korea
      • 7.4.5.5.1 Market size and forecast, by Type
      • 7.4.5.5.2 Market size and forecast, by Treatment Type
      • 7.4.5.5.3 Market size and forecast, by End user
      • 7.4.5.6 Rest of Asia-Pacific
      • 7.4.5.6.1 Market size and forecast, by Type
      • 7.4.5.6.2 Market size and forecast, by Treatment Type
      • 7.4.5.6.3 Market size and forecast, by End user
  • 7.5 LAMEA
    • 7.5.1 Key trends and opportunities
    • 7.5.2 LAMEA Market size and forecast, by Type
    • 7.5.3 LAMEA Market size and forecast, by Treatment Type
      • 7.5.3.1 LAMEA Wound Care Dressing Pressure Ulcers Market by type
      • 7.5.3.2 LAMEA Wound Care Devices Pressure Ulcers Market by type
    • 7.5.4 LAMEA Market size and forecast, by End user
    • 7.5.5 LAMEA Market size and forecast, by country
      • 7.5.5.1 Brazil
      • 7.5.5.1.1 Market size and forecast, by Type
      • 7.5.5.1.2 Market size and forecast, by Treatment Type
      • 7.5.5.1.3 Market size and forecast, by End user
      • 7.5.5.2 Saudi Arabia
      • 7.5.5.2.1 Market size and forecast, by Type
      • 7.5.5.2.2 Market size and forecast, by Treatment Type
      • 7.5.5.2.3 Market size and forecast, by End user
      • 7.5.5.3 South Africa
      • 7.5.5.3.1 Market size and forecast, by Type
      • 7.5.5.3.2 Market size and forecast, by Treatment Type
      • 7.5.5.3.3 Market size and forecast, by End user
      • 7.5.5.4 Rest of LAMEA
      • 7.5.5.4.1 Market size and forecast, by Type
      • 7.5.5.4.2 Market size and forecast, by Treatment Type
      • 7.5.5.4.3 Market size and forecast, by End user

CHAPTER 8: COMPANY LANDSCAPE

  • 8.1. Introduction
  • 8.2. Top winning strategies
  • 8.3. Product Mapping of Top 10 Player
  • 8.4. Competitive Dashboard
  • 8.5. Competitive Heatmap
  • 8.6. Key developments

CHAPTER 9: COMPANY PROFILES

  • 9.1 3M Company
    • 9.1.1 Company overview
    • 9.1.2 Company snapshot
    • 9.1.3 Operating business segments
    • 9.1.4 Product portfolio
    • 9.1.5 Business performance
    • 9.1.6 Key strategic moves and developments
  • 9.2 Abercrombie & Fitch Co (Hollister)
    • 9.2.1 Company overview
    • 9.2.2 Company snapshot
    • 9.2.3 Operating business segments
    • 9.2.4 Product portfolio
    • 9.2.5 Business performance
    • 9.2.6 Key strategic moves and developments
  • 9.3 Anhui Jinye Industrial Co., Ltd
    • 9.3.1 Company overview
    • 9.3.2 Company snapshot
    • 9.3.3 Operating business segments
    • 9.3.4 Product portfolio
    • 9.3.5 Business performance
    • 9.3.6 Key strategic moves and developments
  • 9.4 B. Braun Melungeon AG
    • 9.4.1 Company overview
    • 9.4.2 Company snapshot
    • 9.4.3 Operating business segments
    • 9.4.4 Product portfolio
    • 9.4.5 Business performance
    • 9.4.6 Key strategic moves and developments
  • 9.5 Baxter International (Hill-Rom Holdings, Inc)
    • 9.5.1 Company overview
    • 9.5.2 Company snapshot
    • 9.5.3 Operating business segments
    • 9.5.4 Product portfolio
    • 9.5.5 Business performance
    • 9.5.6 Key strategic moves and developments
  • 9.6 Cardinal Health Inc.
    • 9.6.1 Company overview
    • 9.6.2 Company snapshot
    • 9.6.3 Operating business segments
    • 9.6.4 Product portfolio
    • 9.6.5 Business performance
    • 9.6.6 Key strategic moves and developments
  • 9.7 Coloplast Group
    • 9.7.1 Company overview
    • 9.7.2 Company snapshot
    • 9.7.3 Operating business segments
    • 9.7.4 Product portfolio
    • 9.7.5 Business performance
    • 9.7.6 Key strategic moves and developments
  • 9.8 ConvaTec Group Plc
    • 9.8.1 Company overview
    • 9.8.2 Company snapshot
    • 9.8.3 Operating business segments
    • 9.8.4 Product portfolio
    • 9.8.5 Business performance
    • 9.8.6 Key strategic moves and developments
  • 9.9 Essity (BSN medical)
    • 9.9.1 Company overview
    • 9.9.2 Company snapshot
    • 9.9.3 Operating business segments
    • 9.9.4 Product portfolio
    • 9.9.5 Business performance
    • 9.9.6 Key strategic moves and developments
  • 9.10 Integra LifeSciences (Derma Sciences Inc)
    • 9.10.1 Company overview
    • 9.10.2 Company snapshot
    • 9.10.3 Operating business segments
    • 9.10.4 Product portfolio
    • 9.10.5 Business performance
    • 9.10.6 Key strategic moves and developments
  • 9.11 Johnson and Johnson
    • 9.11.1 Company overview
    • 9.11.2 Company snapshot
    • 9.11.3 Operating business segments
    • 9.11.4 Product portfolio
    • 9.11.5 Business performance
    • 9.11.6 Key strategic moves and developments
  • 9.12 Smith & Nephew plc
    • 9.12.1 Company overview
    • 9.12.2 Company snapshot
    • 9.12.3 Operating business segments
    • 9.12.4 Product portfolio
    • 9.12.5 Business performance
    • 9.12.6 Key strategic moves and developments
  • 9.13 Stryker Corp
    • 9.13.1 Company overview
    • 9.13.2 Company snapshot
    • 9.13.3 Operating business segments
    • 9.13.4 Product portfolio
    • 9.13.5 Business performance
    • 9.13.6 Key strategic moves and developments
  • 9.14 Tissue Regenix
    • 9.14.1 Company overview
    • 9.14.2 Company snapshot
    • 9.14.3 Operating business segments
    • 9.14.4 Product portfolio
    • 9.14.5 Business performance
    • 9.14.6 Key strategic moves and developments
  • 9.15 Investor AB (Molnlycke Healthcare AB)
    • 9.15.1 Company overview
    • 9.15.2 Company snapshot
    • 9.15.3 Operating business segments
    • 9.15.4 Product portfolio
    • 9.15.5 Business performance
    • 9.15.6 Key strategic moves and developments
  • 9.16 Wego Group (Foosin Medical Supplies Inc., Ltd.)
    • 9.16.1 Company overview
    • 9.16.2 Company snapshot
    • 9.16.3 Operating business segments
    • 9.16.4 Product portfolio
    • 9.16.5 Business performance
    • 9.16.6 Key strategic moves and developments
  • 9.17 Shandong Chuangkang Biotechnology Co., Ltd.
    • 9.17.1 Company overview
    • 9.17.2 Company snapshot
    • 9.17.3 Operating business segments
    • 9.17.4 Product portfolio
    • 9.17.5 Business performance
    • 9.17.6 Key strategic moves and developments

LIST OF TABLES

  • TABLE 1. GLOBAL PRESSURE ULCERS MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 2. PRESSURE ULCERS MARKET, FOR STAGE 1, BY REGION, 2021-2031 ($MILLION)
  • TABLE 3. PRESSURE ULCERS MARKET FOR STAGE 1, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 4. PRESSURE ULCERS MARKET, FOR STAGE 2, BY REGION, 2021-2031 ($MILLION)
  • TABLE 5. PRESSURE ULCERS MARKET FOR STAGE 2, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 6. PRESSURE ULCERS MARKET, FOR STAGE 3, BY REGION, 2021-2031 ($MILLION)
  • TABLE 7. PRESSURE ULCERS MARKET FOR STAGE 3, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 8. PRESSURE ULCERS MARKET, FOR STAGE 4, BY REGION, 2021-2031 ($MILLION)
  • TABLE 9. PRESSURE ULCERS MARKET FOR STAGE 4, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 10. PRESSURE ULCERS MARKET, FOR DEEP TISSUE INJURY, BY REGION, 2021-2031 ($MILLION)
  • TABLE 11. PRESSURE ULCERS MARKET FOR DEEP TISSUE INJURY, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 12. GLOBAL PRESSURE ULCERS MARKET, BY TREATMENT TYPE, 2021-2031 ($MILLION)
  • TABLE 13. PRESSURE ULCERS MARKET, FOR WOUND CARE DRESSING, BY REGION, 2021-2031 ($MILLION)
  • TABLE 14. PRESSURE ULCERS MARKET FOR WOUND CARE DRESSING, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 15. GLOBAL WOUND CARE DRESSING PRESSURE ULCERS MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 16. PRESSURE ULCERS MARKET, FOR FOAM DRESSINGS, BY REGION, 2021-2031 ($MILLION)
  • TABLE 17. PRESSURE ULCERS MARKET, FOR HYDROCOLLOID DRESSINGS, BY REGION, 2021-2031 ($MILLION)
  • TABLE 18. PRESSURE ULCERS MARKET, FOR ALGINATE DRESSINGS, BY REGION, 2021-2031 ($MILLION)
  • TABLE 19. PRESSURE ULCERS MARKET, FOR OTHER DRESSINGS, BY REGION, 2021-2031 ($MILLION)
  • TABLE 20. PRESSURE ULCERS MARKET, FOR WOUND CARE DEVICES, BY REGION, 2021-2031 ($MILLION)
  • TABLE 21. PRESSURE ULCERS MARKET FOR WOUND CARE DEVICES, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 22. GLOBAL WOUND CARE DEVICES PRESSURE ULCERS MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 23. PRESSURE ULCERS MARKET, FOR THERAPY DEVICES, BY REGION, 2021-2031 ($MILLION)
  • TABLE 24. PRESSURE ULCERS MARKET, FOR OTHERS, BY REGION, 2021-2031 ($MILLION)
  • TABLE 25. PRESSURE ULCERS MARKET, FOR OTHERS, BY REGION, 2021-2031 ($MILLION)
  • TABLE 26. PRESSURE ULCERS MARKET FOR OTHERS, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 27. GLOBAL PRESSURE ULCERS MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 28. PRESSURE ULCERS MARKET, FOR HOSPITALS, BY REGION, 2021-2031 ($MILLION)
  • TABLE 29. PRESSURE ULCERS MARKET FOR HOSPITALS, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 30. PRESSURE ULCERS MARKET, FOR HOMECARE, BY REGION, 2021-2031 ($MILLION)
  • TABLE 31. PRESSURE ULCERS MARKET FOR HOMECARE, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 32. PRESSURE ULCERS MARKET, FOR OTHERS, BY REGION, 2021-2031 ($MILLION)
  • TABLE 33. PRESSURE ULCERS MARKET FOR OTHERS, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 34. PRESSURE ULCERS MARKET, BY REGION, 2021-2031 ($MILLION)
  • TABLE 35. NORTH AMERICA PRESSURE ULCERS MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 36. NORTH AMERICA PRESSURE ULCERS MARKET, BY TREATMENT TYPE, 2021-2031 ($MILLION)
  • TABLE 37. NORTH AMERICA WOUND CARE DRESSING PRESSURE ULCERS MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 38. NORTH AMERICA WOUND CARE DEVICES PRESSURE ULCERS MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 39. NORTH AMERICA PRESSURE ULCERS MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 40. NORTH AMERICA PRESSURE ULCERS MARKET, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 41. U.S. PRESSURE ULCERS MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 42. U.S. PRESSURE ULCERS MARKET, BY TREATMENT TYPE, 2021-2031 ($MILLION)
  • TABLE 43. U.S. PRESSURE ULCERS MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 44. CANADA PRESSURE ULCERS MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 45. CANADA PRESSURE ULCERS MARKET, BY TREATMENT TYPE, 2021-2031 ($MILLION)
  • TABLE 46. CANADA PRESSURE ULCERS MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 47. MEXICO PRESSURE ULCERS MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 48. MEXICO PRESSURE ULCERS MARKET, BY TREATMENT TYPE, 2021-2031 ($MILLION)
  • TABLE 49. MEXICO PRESSURE ULCERS MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 50. EUROPE PRESSURE ULCERS MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 51. EUROPE PRESSURE ULCERS MARKET, BY TREATMENT TYPE, 2021-2031 ($MILLION)
  • TABLE 52. EUROPE WOUND CARE DRESSING PRESSURE ULCERS MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 53. EUROPE WOUND CARE DEVICES PRESSURE ULCERS MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 54. EUROPE PRESSURE ULCERS MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 55. EUROPE PRESSURE ULCERS MARKET, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 56. GERMANY PRESSURE ULCERS MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 57. GERMANY PRESSURE ULCERS MARKET, BY TREATMENT TYPE, 2021-2031 ($MILLION)
  • TABLE 58. GERMANY PRESSURE ULCERS MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 59. FRANCE PRESSURE ULCERS MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 60. FRANCE PRESSURE ULCERS MARKET, BY TREATMENT TYPE, 2021-2031 ($MILLION)
  • TABLE 61. FRANCE PRESSURE ULCERS MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 62. UK PRESSURE ULCERS MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 63. UK PRESSURE ULCERS MARKET, BY TREATMENT TYPE, 2021-2031 ($MILLION)
  • TABLE 64. UK PRESSURE ULCERS MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 65. ITALY PRESSURE ULCERS MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 66. ITALY PRESSURE ULCERS MARKET, BY TREATMENT TYPE, 2021-2031 ($MILLION)
  • TABLE 67. ITALY PRESSURE ULCERS MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 68. SPAIN PRESSURE ULCERS MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 69. SPAIN PRESSURE ULCERS MARKET, BY TREATMENT TYPE, 2021-2031 ($MILLION)
  • TABLE 70. SPAIN PRESSURE ULCERS MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 71. REST OF LAMEA PRESSURE ULCERS MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 72. REST OF LAMEA PRESSURE ULCERS MARKET, BY TREATMENT TYPE, 2021-2031 ($MILLION)
  • TABLE 73. REST OF LAMEA PRESSURE ULCERS MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 74. ASIA-PACIFIC PRESSURE ULCERS MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 75. ASIA-PACIFIC PRESSURE ULCERS MARKET, BY TREATMENT TYPE, 2021-2031 ($MILLION)
  • TABLE 76. ASIA-PACIFIC WOUND CARE DRESSING PRESSURE ULCERS MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 77. ASIA-PACIFIC WOUND CARE DEVICES PRESSURE ULCERS MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 78. ASIA-PACIFIC PRESSURE ULCERS MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 79. ASIA-PACIFIC PRESSURE ULCERS MARKET, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 80. JAPAN PRESSURE ULCERS MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 81. JAPAN PRESSURE ULCERS MARKET, BY TREATMENT TYPE, 2021-2031 ($MILLION)
  • TABLE 82. JAPAN PRESSURE ULCERS MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 83. CHINA PRESSURE ULCERS MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 84. CHINA PRESSURE ULCERS MARKET, BY TREATMENT TYPE, 2021-2031 ($MILLION)
  • TABLE 85. CHINA PRESSURE ULCERS MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 86. AUSTRALIA PRESSURE ULCERS MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 87. AUSTRALIA PRESSURE ULCERS MARKET, BY TREATMENT TYPE, 2021-2031 ($MILLION)
  • TABLE 88. AUSTRALIA PRESSURE ULCERS MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 89. INDIA PRESSURE ULCERS MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 90. INDIA PRESSURE ULCERS MARKET, BY TREATMENT TYPE, 2021-2031 ($MILLION)
  • TABLE 91. INDIA PRESSURE ULCERS MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 92. SOUTH KOREA PRESSURE ULCERS MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 93. SOUTH KOREA PRESSURE ULCERS MARKET, BY TREATMENT TYPE, 2021-2031 ($MILLION)
  • TABLE 94. SOUTH KOREA PRESSURE ULCERS MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 95. REST OF ASIA-PACIFIC PRESSURE ULCERS MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 96. REST OF ASIA-PACIFIC PRESSURE ULCERS MARKET, BY TREATMENT TYPE, 2021-2031 ($MILLION)
  • TABLE 97. REST OF ASIA-PACIFIC PRESSURE ULCERS MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 98. LAMEA PRESSURE ULCERS MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 99. LAMEA PRESSURE ULCERS MARKET, BY TREATMENT TYPE, 2021-2031 ($MILLION)
  • TABLE 100. LAMEA WOUND CARE DRESSING PRESSURE ULCERS MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 101. LAMEA WOUND CARE DEVICES PRESSURE ULCERS MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 102. LAMEA PRESSURE ULCERS MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 103. LAMEA PRESSURE ULCERS MARKET, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 104. BRAZIL PRESSURE ULCERS MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 105. BRAZIL PRESSURE ULCERS MARKET, BY TREATMENT TYPE, 2021-2031 ($MILLION)
  • TABLE 106. BRAZIL PRESSURE ULCERS MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 107. SAUDI ARABIA PRESSURE ULCERS MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 108. SAUDI ARABIA PRESSURE ULCERS MARKET, BY TREATMENT TYPE, 2021-2031 ($MILLION)
  • TABLE 109. SAUDI ARABIA PRESSURE ULCERS MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 110. SOUTH AFRICA PRESSURE ULCERS MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 111. SOUTH AFRICA PRESSURE ULCERS MARKET, BY TREATMENT TYPE, 2021-2031 ($MILLION)
  • TABLE 112. SOUTH AFRICA PRESSURE ULCERS MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 113. REST OF LAMEA PRESSURE ULCERS MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 114. REST OF LAMEA PRESSURE ULCERS MARKET, BY TREATMENT TYPE, 2021-2031 ($MILLION)
  • TABLE 115. REST OF LAMEA PRESSURE ULCERS MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 116.3M COMPANY: COMPANY SNAPSHOT
  • TABLE 117.3M COMPANY: OPERATING SEGMENTS
  • TABLE 118.3M COMPANY: PRODUCT PORTFOLIO
  • TABLE 119.3M COMPANY: NET SALES,
  • TABLE 120.3M COMPANY: KEY STRATERGIES
  • TABLE 121.ABERCROMBIE & FITCH CO (HOLLISTER): COMPANY SNAPSHOT
  • TABLE 122.ABERCROMBIE & FITCH CO (HOLLISTER): OPERATING SEGMENTS
  • TABLE 123.ABERCROMBIE & FITCH CO (HOLLISTER): PRODUCT PORTFOLIO
  • TABLE 124.ABERCROMBIE & FITCH CO (HOLLISTER): NET SALES,
  • TABLE 125.ABERCROMBIE & FITCH CO (HOLLISTER): KEY STRATERGIES
  • TABLE 126.ANHUI JINYE INDUSTRIAL CO., LTD: COMPANY SNAPSHOT
  • TABLE 127.ANHUI JINYE INDUSTRIAL CO., LTD: OPERATING SEGMENTS
  • TABLE 128.ANHUI JINYE INDUSTRIAL CO., LTD: PRODUCT PORTFOLIO
  • TABLE 129.ANHUI JINYE INDUSTRIAL CO., LTD: NET SALES,
  • TABLE 130.ANHUI JINYE INDUSTRIAL CO., LTD: KEY STRATERGIES
  • TABLE 131.B. BRAUN MELUNGEON AG: COMPANY SNAPSHOT
  • TABLE 132.B. BRAUN MELUNGEON AG: OPERATING SEGMENTS
  • TABLE 133.B. BRAUN MELUNGEON AG: PRODUCT PORTFOLIO
  • TABLE 134.B. BRAUN MELUNGEON AG: NET SALES,
  • TABLE 135.B. BRAUN MELUNGEON AG: KEY STRATERGIES
  • TABLE 136.BAXTER INTERNATIONAL (HILL-ROM HOLDINGS, INC): COMPANY SNAPSHOT
  • TABLE 137.BAXTER INTERNATIONAL (HILL-ROM HOLDINGS, INC): OPERATING SEGMENTS
  • TABLE 138.BAXTER INTERNATIONAL (HILL-ROM HOLDINGS, INC): PRODUCT PORTFOLIO
  • TABLE 139.BAXTER INTERNATIONAL (HILL-ROM HOLDINGS, INC): NET SALES,
  • TABLE 140.BAXTER INTERNATIONAL (HILL-ROM HOLDINGS, INC): KEY STRATERGIES
  • TABLE 141.CARDINAL HEALTH INC.: COMPANY SNAPSHOT
  • TABLE 142.CARDINAL HEALTH INC.: OPERATING SEGMENTS
  • TABLE 143.CARDINAL HEALTH INC.: PRODUCT PORTFOLIO
  • TABLE 144.CARDINAL HEALTH INC.: NET SALES,
  • TABLE 145.CARDINAL HEALTH INC.: KEY STRATERGIES
  • TABLE 146.COLOPLAST GROUP: COMPANY SNAPSHOT
  • TABLE 147.COLOPLAST GROUP: OPERATING SEGMENTS
  • TABLE 148.COLOPLAST GROUP: PRODUCT PORTFOLIO
  • TABLE 149.COLOPLAST GROUP: NET SALES,
  • TABLE 150.COLOPLAST GROUP: KEY STRATERGIES
  • TABLE 151.CONVATEC GROUP PLC: COMPANY SNAPSHOT
  • TABLE 152.CONVATEC GROUP PLC: OPERATING SEGMENTS
  • TABLE 153.CONVATEC GROUP PLC: PRODUCT PORTFOLIO
  • TABLE 154.CONVATEC GROUP PLC: NET SALES,
  • TABLE 155.CONVATEC GROUP PLC: KEY STRATERGIES
  • TABLE 156.ESSITY (BSN MEDICAL): COMPANY SNAPSHOT
  • TABLE 157.ESSITY (BSN MEDICAL): OPERATING SEGMENTS
  • TABLE 158.ESSITY (BSN MEDICAL): PRODUCT PORTFOLIO
  • TABLE 159.ESSITY (BSN MEDICAL): NET SALES,
  • TABLE 160.ESSITY (BSN MEDICAL): KEY STRATERGIES
  • TABLE 161.INTEGRA LIFESCIENCES (DERMA SCIENCES INC): COMPANY SNAPSHOT
  • TABLE 162.INTEGRA LIFESCIENCES (DERMA SCIENCES INC): OPERATING SEGMENTS
  • TABLE 163.INTEGRA LIFESCIENCES (DERMA SCIENCES INC): PRODUCT PORTFOLIO
  • TABLE 164.INTEGRA LIFESCIENCES (DERMA SCIENCES INC): NET SALES,
  • TABLE 165.INTEGRA LIFESCIENCES (DERMA SCIENCES INC): KEY STRATERGIES
  • TABLE 166.JOHNSON AND JOHNSON: COMPANY SNAPSHOT
  • TABLE 167.JOHNSON AND JOHNSON: OPERATING SEGMENTS
  • TABLE 168.JOHNSON AND JOHNSON: PRODUCT PORTFOLIO
  • TABLE 169.JOHNSON AND JOHNSON: NET SALES,
  • TABLE 170.JOHNSON AND JOHNSON: KEY STRATERGIES
  • TABLE 171.SMITH & NEPHEW PLC: COMPANY SNAPSHOT
  • TABLE 172.SMITH & NEPHEW PLC: OPERATING SEGMENTS
  • TABLE 173.SMITH & NEPHEW PLC: PRODUCT PORTFOLIO
  • TABLE 174.SMITH & NEPHEW PLC: NET SALES,
  • TABLE 175.SMITH & NEPHEW PLC: KEY STRATERGIES
  • TABLE 176.STRYKER CORP: COMPANY SNAPSHOT
  • TABLE 177.STRYKER CORP: OPERATING SEGMENTS
  • TABLE 178.STRYKER CORP: PRODUCT PORTFOLIO
  • TABLE 179.STRYKER CORP: NET SALES,
  • TABLE 180.STRYKER CORP: KEY STRATERGIES
  • TABLE 181.TISSUE REGENIX: COMPANY SNAPSHOT
  • TABLE 182.TISSUE REGENIX: OPERATING SEGMENTS
  • TABLE 183.TISSUE REGENIX: PRODUCT PORTFOLIO
  • TABLE 184.TISSUE REGENIX: NET SALES,
  • TABLE 185.TISSUE REGENIX: KEY STRATERGIES
  • TABLE 186.INVESTOR AB (MOLNLYCKE HEALTHCARE AB): COMPANY SNAPSHOT
  • TABLE 187.INVESTOR AB (MOLNLYCKE HEALTHCARE AB): OPERATING SEGMENTS
  • TABLE 188.INVESTOR AB (MOLNLYCKE HEALTHCARE AB): PRODUCT PORTFOLIO
  • TABLE 189.INVESTOR AB (MOLNLYCKE HEALTHCARE AB): NET SALES,
  • TABLE 190.INVESTOR AB (MOLNLYCKE HEALTHCARE AB): KEY STRATERGIES
  • TABLE 191.WEGO GROUP (FOOSIN MEDICAL SUPPLIES INC., LTD.): COMPANY SNAPSHOT
  • TABLE 192.WEGO GROUP (FOOSIN MEDICAL SUPPLIES INC., LTD.): OPERATING SEGMENTS
  • TABLE 193.WEGO GROUP (FOOSIN MEDICAL SUPPLIES INC., LTD.): PRODUCT PORTFOLIO
  • TABLE 194.WEGO GROUP (FOOSIN MEDICAL SUPPLIES INC., LTD.): NET SALES,
  • TABLE 195.WEGO GROUP (FOOSIN MEDICAL SUPPLIES INC., LTD.): KEY STRATERGIES
  • TABLE 196.SHANDONG CHUANGKANG BIOTECHNOLOGY CO., LTD.: COMPANY SNAPSHOT
  • TABLE 197.SHANDONG CHUANGKANG BIOTECHNOLOGY CO., LTD.: OPERATING SEGMENTS
  • TABLE 198.SHANDONG CHUANGKANG BIOTECHNOLOGY CO., LTD.: PRODUCT PORTFOLIO
  • TABLE 199.SHANDONG CHUANGKANG BIOTECHNOLOGY CO., LTD.: NET SALES,
  • TABLE 200.SHANDONG CHUANGKANG BIOTECHNOLOGY CO., LTD.: KEY STRATERGIES

LIST OF FIGURES

  • FIGURE 1.PRESSURE ULCERS MARKET SEGMENTATION
  • FIGURE 2.PRESSURE ULCERS MARKET,2021-2031
  • FIGURE 3.PRESSURE ULCERS MARKET,2021-2031
  • FIGURE 4. TOP INVESTMENT POCKETS, BY REGION
  • FIGURE 5.PORTER FIVE-1
  • FIGURE 6.PORTER FIVE-2
  • FIGURE 7.PORTER FIVE-3
  • FIGURE 8.PORTER FIVE-4
  • FIGURE 9.PORTER FIVE-5
  • FIGURE 10.TOP PLAYER POSITIONING
  • FIGURE 11.PRESSURE ULCERS MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
  • FIGURE 12.PRESSURE ULCERS MARKET,BY TYPE,2021(%)
  • FIGURE 13.COMPARATIVE SHARE ANALYSIS OF STAGE 1 PRESSURE ULCERS MARKET,2021-2031(%)
  • FIGURE 14.COMPARATIVE SHARE ANALYSIS OF STAGE 2 PRESSURE ULCERS MARKET,2021-2031(%)
  • FIGURE 15.COMPARATIVE SHARE ANALYSIS OF STAGE 3 PRESSURE ULCERS MARKET,2021-2031(%)
  • FIGURE 16.COMPARATIVE SHARE ANALYSIS OF STAGE 4 PRESSURE ULCERS MARKET,2021-2031(%)
  • FIGURE 17.COMPARATIVE SHARE ANALYSIS OF DEEP TISSUE INJURY PRESSURE ULCERS MARKET,2021-2031(%)
  • FIGURE 18.PRESSURE ULCERS MARKET,BY TREATMENT TYPE,2021(%)
  • FIGURE 19.COMPARATIVE SHARE ANALYSIS OF WOUND CARE DRESSING PRESSURE ULCERS MARKET,2021-2031(%)
  • FIGURE 20.COMPARATIVE SHARE ANALYSIS OF WOUND CARE DEVICES PRESSURE ULCERS MARKET,2021-2031(%)
  • FIGURE 21.COMPARATIVE SHARE ANALYSIS OF OTHERS PRESSURE ULCERS MARKET,2021-2031(%)
  • FIGURE 22.PRESSURE ULCERS MARKET,BY END USER,2021(%)
  • FIGURE 23.COMPARATIVE SHARE ANALYSIS OF HOSPITALS PRESSURE ULCERS MARKET,2021-2031(%)
  • FIGURE 24.COMPARATIVE SHARE ANALYSIS OF HOMECARE PRESSURE ULCERS MARKET,2021-2031(%)
  • FIGURE 25.COMPARATIVE SHARE ANALYSIS OF OTHERS PRESSURE ULCERS MARKET,2021-2031(%)
  • FIGURE 26.PRESSURE ULCERS MARKET BY REGION,2021
  • FIGURE 27.U.S. PRESSURE ULCERS MARKET,2021-2031($MILLION)
  • FIGURE 28.CANADA PRESSURE ULCERS MARKET,2021-2031($MILLION)
  • FIGURE 29.MEXICO PRESSURE ULCERS MARKET,2021-2031($MILLION)
  • FIGURE 30.GERMANY PRESSURE ULCERS MARKET,2021-2031($MILLION)
  • FIGURE 31.FRANCE PRESSURE ULCERS MARKET,2021-2031($MILLION)
  • FIGURE 32.UK PRESSURE ULCERS MARKET,2021-2031($MILLION)
  • FIGURE 33.ITALY PRESSURE ULCERS MARKET,2021-2031($MILLION)
  • FIGURE 34.SPAIN PRESSURE ULCERS MARKET,2021-2031($MILLION)
  • FIGURE 35.REST OF LAMEA PRESSURE ULCERS MARKET,2021-2031($MILLION)
  • FIGURE 36.JAPAN PRESSURE ULCERS MARKET,2021-2031($MILLION)
  • FIGURE 37.CHINA PRESSURE ULCERS MARKET,2021-2031($MILLION)
  • FIGURE 38.AUSTRALIA PRESSURE ULCERS MARKET,2021-2031($MILLION)
  • FIGURE 39.INDIA PRESSURE ULCERS MARKET,2021-2031($MILLION)
  • FIGURE 40.SOUTH KOREA PRESSURE ULCERS MARKET,2021-2031($MILLION)
  • FIGURE 41.REST OF ASIA-PACIFIC PRESSURE ULCERS MARKET,2021-2031($MILLION)
  • FIGURE 42.BRAZIL PRESSURE ULCERS MARKET,2021-2031($MILLION)
  • FIGURE 43.SAUDI ARABIA PRESSURE ULCERS MARKET,2021-2031($MILLION)
  • FIGURE 44.SOUTH AFRICA PRESSURE ULCERS MARKET,2021-2031($MILLION)
  • FIGURE 45.REST OF LAMEA PRESSURE ULCERS MARKET,2021-2031($MILLION)
  • FIGURE 46. TOP WINNING STRATEGIES, BY YEAR
  • FIGURE 47. TOP WINNING STRATEGIES, BY DEVELOPMENT
  • FIGURE 48. TOP WINNING STRATEGIES, BY COMPANY
  • FIGURE 49.PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 50.COMPETITIVE DASHBOARD
  • FIGURE 51.COMPETITIVE HEATMAP OF TOP 10 KEY PLAYERS
  • FIGURE 52.3M COMPANY.: NET SALES ,($MILLION)
  • FIGURE 53.ABERCROMBIE & FITCH CO (HOLLISTER).: NET SALES ,($MILLION)
  • FIGURE 54.ANHUI JINYE INDUSTRIAL CO., LTD.: NET SALES ,($MILLION)
  • FIGURE 55.B. BRAUN MELUNGEON AG.: NET SALES ,($MILLION)
  • FIGURE 56.BAXTER INTERNATIONAL (HILL-ROM HOLDINGS, INC).: NET SALES ,($MILLION)
  • FIGURE 57.CARDINAL HEALTH INC..: NET SALES ,($MILLION)
  • FIGURE 58.COLOPLAST GROUP.: NET SALES ,($MILLION)
  • FIGURE 59.CONVATEC GROUP PLC.: NET SALES ,($MILLION)
  • FIGURE 60.ESSITY (BSN MEDICAL).: NET SALES ,($MILLION)
  • FIGURE 61.INTEGRA LIFESCIENCES (DERMA SCIENCES INC).: NET SALES ,($MILLION)
  • FIGURE 62.JOHNSON AND JOHNSON.: NET SALES ,($MILLION)
  • FIGURE 63.SMITH & NEPHEW PLC.: NET SALES ,($MILLION)
  • FIGURE 64.STRYKER CORP.: NET SALES ,($MILLION)
  • FIGURE 65.TISSUE REGENIX.: NET SALES ,($MILLION)
  • FIGURE 66.INVESTOR AB (MOLNLYCKE HEALTHCARE AB).: NET SALES ,($MILLION)
  • FIGURE 67.WEGO GROUP (FOOSIN MEDICAL SUPPLIES INC., LTD.).: NET SALES ,($MILLION)
  • FIGURE 68.SHANDONG CHUANGKANG BIOTECHNOLOGY CO., LTD..: NET SALES ,($MILLION)